Status:
COMPLETED
Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
This observational study is supposed to assess (under conditions of clinical practice in daily routine) whether treatment with Viramune (nevirapine) in combination with ARV, e.g. Combivir (Zidovudine ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- male and female
- 18 years or older
- written informed consent
- The inclusion criteria for treatment with Viramune plus other antiretroviral combination drugs are to be based on the current information for healthcare professionals / SmPC
- Exclusion criteria:
- Pregnant patients
- The exclusion criteria for the treatment of Viramune plus other antiretroviral combination drugs are to be based on the current SmPC
Exclusion
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
605 Patients enrolled
Trial Details
Trial ID
NCT00876733
Start Date
March 1 2009
End Date
December 1 2013
Last Update
January 16 2015
Active Locations (66)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 14
Aachen, Germany
2
Boehringer Ingelheim Investigational Site 12
Berlin, Germany
3
Boehringer Ingelheim Investigational Site 13
Berlin, Germany
4
Boehringer Ingelheim Investigational Site 15
Berlin, Germany